Citadel Advisors’s Design Therapeutics DSGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.46M Sell
231,513
-228,361
-50% -$2.31M ﹤0.01% 5655
2025
Q4
$4.31M Sell
459,874
-94,146
-17% -$737K ﹤0.01% 4509
2025
Q3
$4.17M Sell
554,020
-286,773
-34% -$1.44M ﹤0.01% 4686
2025
Q2
$2.83M Sell
840,793
-122,667
-13% -$459K ﹤0.01% 5067
2025
Q1
$3.72M Buy
963,460
+4,667
+0.5% +$22.3K ﹤0.01% 4381
2024
Q4
$5.92M Buy
958,793
+383,243
+67% +$2.22M 0.01% 3699
2024
Q3
$3.1M Buy
575,550
+270,920
+89% +$1.27M ﹤0.01% 4723
2024
Q2
$1.02M Sell
304,630
-570,147
-65% -$2.22M ﹤0.01% 6536
2024
Q1
$3.53M Sell
874,777
-957,477
-52% -$2.56M ﹤0.01% 4534
2023
Q4
$4.86M Sell
1,832,254
-868,299
-32% -$1.99M ﹤0.01% 3838
2023
Q3
$6.37M Sell
2,700,553
-155,553
-5% -$726K 0.01% 3286
2023
Q2
$18M Sell
2,856,106
-9,061
-0.3% -$55.4K 0.02% 1993
2023
Q1
$16.5M Buy
2,865,167
+362,606
+14% +$2.71M 0.02% 2146
2022
Q4
$25.7M Buy
2,502,561
+80,829
+3% +$1.1M 0.03% 1703
2022
Q3
$40.5M Sell
2,421,732
-123,926
-5% -$2.47M 0.05% 1236
2022
Q2
$35.6M Buy
2,545,658
+10,956
+0.4% +$148K 0.05% 1305
2022
Q1
$40.9M Hold
2,534,702
0.05% 1267
2021
Q4
$54.3M Sell
2,534,702
-37,828
-1% -$650K 0.06% 1104
2021
Q3
$37.8M Buy
2,572,530
+6,382
+0.2% +$106K 0.04% 1339
2021
Q2
$49.9M Buy
2,566,148
+31,445
+1% +$794K 0.05% 1126
2021
Q1
$75.8M Buy
+2,534,703
New +$85.5M 0.08% 744

Other funds holding DSGN